Total Payments
$10,885
2024 Payments
$3,368
Companies
32
Transactions
100
Payment Breakdown by Category
Food & Beverage$5,280 (48.5%)
Consulting$3,775 (34.7%)
Other$1,435 (13.2%)
Travel$250.00 (2.3%)
Education$144.34 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,280 | 80 | 48.5% |
| Consulting Fee | $3,775 | 8 | 34.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,075 | 4 | 9.9% |
| Honoraria | $360.00 | 1 | 3.3% |
| Travel and Lodging | $250.00 | 1 | 2.3% |
| Education | $144.34 | 6 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,100 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,691 | 23 | $0 (2024) |
| BeiGene USA, Inc. | $675.00 | 1 | $0 (2024) |
| Amgen Inc. | $503.27 | 7 | $0 (2021) |
| Incyte Corporation | $500.00 | 2 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $491.54 | 4 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $459.94 | 3 | $0 (2021) |
| GENZYME CORPORATION | $375.00 | 1 | $0 (2021) |
| Daiichi Sankyo Inc. | $360.00 | 1 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $350.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,368 | 9 | AstraZeneca Pharmaceuticals LP ($2,500) |
| 2023 | $1,494 | 14 | Incyte Corporation ($500.00) |
| 2022 | $1,203 | 10 | E.R. Squibb & Sons, L.L.C. ($507.78) |
| 2021 | $1,946 | 14 | GENZYME CORPORATION ($375.00) |
| 2020 | $57.49 | 4 | E.R. Squibb & Sons, L.L.C. ($32.96) |
| 2019 | $895.05 | 18 | AstraZeneca Pharmaceuticals LP ($255.85) |
| 2018 | $1,378 | 21 | AstraZeneca Pharmaceuticals LP ($343.82) |
| 2017 | $542.76 | 10 | E.R. Squibb & Sons, L.L.C. ($165.54) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | Truqap (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 11/26/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Oncology | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Immunocore Limited | KIMMTRAK (Drug) | Food and Beverage | In-kind items and services | $55.26 | General |
| Category: Oncology | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 04/27/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Oncology | ||||||
| 04/22/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $113.73 | General |
| Category: Oncology | ||||||
| 03/06/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 01/19/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $23.74 | General |
| Category: Oncology | ||||||
| 12/04/2023 | Daiichi Sankyo Inc. | — | Honoraria | Cash or cash equivalent | $360.00 | General |
| 09/28/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $24.19 | General |
| Category: Oncology | ||||||
| 09/01/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $13.03 | General |
| Category: Oncology | ||||||
| 08/17/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $25.28 | General |
| Category: Oncology | ||||||
| 08/14/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $59.48 | General |
| 05/25/2023 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 05/19/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $38.59 | General |
| Category: ONCOLOGY | ||||||
| 04/21/2023 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $250.00 | General |
| 04/05/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| 03/16/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $47.18 | General |
| 03/15/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $120.40 | General |
| Category: Oncology | ||||||
| 02/16/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $67.53 | General |
| 02/08/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $42.26 | General |
| Category: ONCOLOGY | ||||||
| 01/20/2023 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $71.29 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/29/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $124.88 | General |
| 09/08/2022 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $119.18 | General |
About Dr. Sam Yeh, MD
Dr. Sam Yeh, MD is a Hematology & Oncology healthcare provider based in Riverside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689741498.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sam Yeh, MD has received a total of $10,885 in payments from pharmaceutical and medical device companies, with $3,368 received in 2024. These payments were reported across 100 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,280).
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Riverside, CA
- Active Since 11/29/2006
- Last Updated 12/01/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1689741498
Products in Payments
- IMFINZI (Biological) $1,975
- BRUKINSA (Drug) $675.00
- OPDIVO (Biological) $621.84
- Truqap (Drug) $525.00
- ALPROLIX (Biological) $375.00
- CARVYKTI (Drug) $350.00
- LIBTAYO (Biological) $350.00
- IMLYGIC (Biological) $289.62
- VENCLEXTA (Drug) $257.72
- TAGRISSO (Drug) $249.34
- LYNPARZA (Drug) $225.33
- KEYTRUDA (Biological) $204.47
- XPOVIO (Drug) $150.55
- UKONIQ (Drug) $149.15
- Yescarta (Drug) $133.91
- BAVENCIO (Drug) $133.43
- ONIVYDE (Drug) $126.53
- IMFINZI (Drug) $125.00
- SOMATULINE DEPOT (Drug) $125.00
- TIBSOVO (Drug) $124.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Riverside
Vaishali Saste, M.d, M.D
Hematology & Oncology — Payments: $15,275
Hematology & Oncology $15,275
Dr. Andy Jang, Md, MD
Hematology & Oncology — Payments: $14,591
Hematology & Oncology $14,591
Ngan Nguyen, D.o, D.O
Hematology & Oncology — Payments: $8,008
Hematology & Oncology $8,008
Xinting Fu, Md, MD
Hematology & Oncology — Payments: $7,449
Hematology & Oncology $7,449
Soe Maunglay, Md, MD
Hematology & Oncology — Payments: $4,421
Hematology & Oncology $4,421
Muhammad Muslim, Md, MD
Hematology & Oncology — Payments: $3,975
Hematology & Oncology $3,975